Drug Discovery Today

1

A minimalist fragment approach for the design of natural-product-like synthetic scaffolds

Dmitry Genis, Mikhail Kirpichenok, Roman Kombarov

Journal:

Year:

2012

Language:

english

File:

PDF, 285 KB

english, 2012

2

Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare

Ruth Wellenreuther, Dietrich Keppler, Dominik Mumberg, Karl Ziegelbauer, Monika Lessl

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 370 KB

english, 2012

3

What is the most important approach in current drug discovery: doing the right things or doing things right?

Thomas Elebring, Adrian Gill, Alleyn T. Plowright

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 299 KB

english, 2012

4

Open PHACTS: semantic interoperability for drug discovery

Antony J. Williams, Lee Harland, Paul Groth, Stephen Pettifer, Christine Chichester, Egon L. Willighagen, Chris T. Evelo, Niklas Blomberg, Gerhard Ecker, Carole Goble, Barend Mons

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 596 KB

english, 2012

5

The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease

Bert A. ’t Hart, David H. Abbott, Katsuki Nakamura, Eberhard Fuchs

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 614 KB

english, 2012

6

Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents

Ajay Kumar, Kamla Pathak, Vikas Bali

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 476 KB

english, 2012

7

Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases

Hongkang Mei, Tian Xia, Gang Feng, Jason Zhu, Simon M. Lin, Yang Qiu

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 1.59 MB

english, 2012

8

PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET

Paul Slobbe, Alex J. Poot, Albert D. Windhorst, Guus A.M.S. van Dongen

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 1.65 MB

english, 2012

9

Targeting mutant huntingtin for the development of disease-modifying therapy

Thomas Appl, Linda Kaltenbach, Donald C. Lo, Georg C. Terstappen

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 321 KB

english, 2012

10

Nucleic acid sample preparation for in vitro molecular diagnosis: from conventional techniques to biotechnology

Md Mahbubor Rahman, Abdelhamid Elaissari

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 1010 KB

english, 2012

11

Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design

Seyed Jalal Hosseinimehr, Vladimir Tolmachev, Anna Orlova

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 499 KB

english, 2012

12

What are the prospects of slowing the progression of Alzheimer's disease?

Alan M. Palmer

Journal:

Drug Discovery Today

Year:

2012

Language:

english

File:

PDF, 119 KB

english, 2012

13

Volume 17; Issue 21-22

A minimalist fragment approach for the design of natural-product-like synthetic scaffolds

Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare

What is the most important approach in current drug discovery: doing the right things or doing things right?

Open PHACTS: semantic interoperability for drug discovery

The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease

Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents

Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases

PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET

Targeting mutant huntingtin for the development of disease-modifying therapy

Nucleic acid sample preparation for in vitro molecular diagnosis: from conventional techniques to biotechnology

Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design

What are the prospects of slowing the progression of Alzheimer's disease?

Contents

Contents